
PT-141, also called Bremelanotide (generic clinical name), is a heavily modified synthetic derivative of alpha-melanocyte-stimulating hormone. It has been tested in clinical trials as a treatment for both male/female hypoactive sexual desire disorder and acute hemorrhage. PT-141 is an agonist for the melanocortin-4 and melanocortin-1 receptors. Research shows that it promotes sexual arousal and stimulates the immune system.

TIRZEPATIDE (mounjaro) VIAL (USA WAREHOUSE)
CJC1295 NO DAC IN KIT OF 10 VIALS (USA WAREHOUSE)
HMG 75iu/vial 10vials kits (USA WAREHOUSE)
BAM 15 IN KIT OF 10 VIALS (USA WAREHOUSE) 

